Abstract
Several classes of compounds, including heterocyclic polyamides, aryl benzimidazoles, pyrrolobenzodiazepines, amidino arylfurans and benzofurans, have been found to bind to the minor groove of DNA with sequence selectivity and potential therapeutic consequences. Many such compounds are synthetic analogues of natural products such as distamycin, netropsin, CC-1065, duocarmycin and anthramycin. Biological activity has been demonstrated in antibacterial, antifungal, antiviral and anticancer applications, and several compounds are in clinical trials. This review covers patents since 1998 and reviews the structures, mechanisms and biological activity of minor groove binders in the context of the current scientific understanding described in the journal literature.
| Original language | English |
|---|---|
| Pages (from-to) | 1693-1724 |
| Number of pages | 31 |
| Journal | Expert Opinion on Therapeutic Patents |
| Volume | 14 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 1 Dec 2004 |
Keywords
- antibacterial agent
- antifungal agent
- antiviral agent
- aryl benzimidazole
- cancer chemotherapy
- DNA binding compound
- heterocyclic polyamide
- minor groove
- natural product analogue
- pyrrolobenzodiazepine
Fingerprint Dive into the research topics of 'Minor groove binders 1998-2004'. Together they form a unique fingerprint.
Cite this
Suckling, C. J. (2004). Minor groove binders 1998-2004. Expert Opinion on Therapeutic Patents, 14(12), 1693-1724. https://doi.org/10.1517/13543776.14.12.1693